Received Mar 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | UNK | Unknown | PO / MO |
Patient took Vivotif accidentally every day instead of every other day; Case reference number US-BN-2024-001861 is a spontaneous case report initially received from a pharmacist via Med Communication (reference number: USBAV24-0913) on 02-May-2024 and concerns male patient of unspecified age. The patient's relevant medical history and concomitant medications were not provided. On unspecified dates, the patient took Vivotif (batch number: unknown), orally, at unknown dose for unknown indication. As reported, the patient took Vivotif vaccine accidentally every day instead of every other day (explicitly coded as 'inappropriate schedule of vaccine administered'). At the time of initial report, it was unknown if the patient experienced any adverse event due to Vivotif vaccine. No further information provided.; Reporter's Comments: A male patient of unspecified age took Vivotif, orally every day instead of every other day which is considered as inappropriate schedule of vaccine administered. Inappropriate schedule of product administration is considered listed per company conventions. At this point, it was unknown if the patient experienced any adverse event due to Vivotif vaccine. The patient's relevant medical history and concomitant medications were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.; Sender's Comments: A male patient of unspecified age took Vivotif, orally every day instead of every other day which is considered as inappropriate schedule of vaccine administered. Inappropriate schedule of product administration is considered listed per company conventions. At this point, it was unknown if the patient experienced any adverse event due to Vivotif vaccine. The patient's relevant medical history and concomitant medications were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.
Comments: None